Forte Biosciences (FBRX) Reports In-Line Q1 EPS
Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.
Forte Biosciences (NASDAQ: FBRX) reported Q1 EPS of ($0.16), in-line with the analyst estimate of ($0.16).
For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.